Université de Sherbrooke
343
59
78
185
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.9%
10 terminated/withdrawn out of 343 trials
94.9%
+8.3% vs industry average
9%
30 trials in Phase 3/4
10%
19 of 185 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (343)
Improving Access to Pelvic Health Physiotherapy for Endometriosis
Role: lead
4FMFES-PET Imaging of ER+ Advanced Breast Cancers
Role: collaborator
Pain Beliefs and Intracortical Excitability During Experimental Pain
Role: lead
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
Role: lead
Canadian Critical Care Comparative Effectiveness Platform
Role: lead
Immersive Virtual Reality for Older Adults in Long-Term Care Settings
Role: collaborator
Efficacy of High Intensity Laser for Provoked Vestibulodynia
Role: lead
Virtual Reality for Pain and Well-Being in Older Adults
Role: collaborator
Integrated HIV Prevention and HCV Care for PWID
Role: collaborator
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
Role: collaborator
Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis
Role: lead
Predicting Breast Cancer With the BRAVE System
Role: lead
Surveillance of Complex Renal Cysts - The SOCRATIC Study
Role: lead
Therapeutic Climbing for Children With DCD
Role: lead
DNIC Using Deep Learning and Artificial Intelligence
Role: lead
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
Role: collaborator
Female Reproductive Health in Canadian Armed Forces
Role: lead
Recovery With Exogenous Ketones and Antipsychotics
Role: lead
Efficacy of Dry Needling in Reducing Pain During Sexual Intercourse
Role: lead
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors
Role: lead